Skip to main content
Clinical Trials/NCT02691403
NCT02691403
Unknown
Phase 4

Ultrasound-guided Quadratus Lumborum Block for Postoperative Analgesia After Colostomy: A Randomized Controlled Trial

Sun Yat-sen University0 sites50 target enrollmentMarch 2016

Overview

Phase
Phase 4
Intervention
normal saline
Conditions
Postoperative Pain
Sponsor
Sun Yat-sen University
Enrollment
50
Primary Endpoint
cumulative morphine consumption
Last Updated
10 years ago

Overview

Brief Summary

Patients undergoing abdominal procedures often require multimodal postoperative pain controls. Truncal blocks such as quadratus lumborum (QL) block may be used adjunctively as a part of it. The investigators hypothesized that the ultrasound-guided QL block with transmuscular approach can provide adequate pain relief for colostomy closure as part of a multimodal pain control.

Registry
clinicaltrials.gov
Start Date
March 2016
End Date
June 2017
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Sun Yat-sen University
Responsible Party
Principal Investigator
Principal Investigator

Nai Liang Li

Doctor

Sun Yat-sen University

Eligibility Criteria

Inclusion Criteria

  • A physical status between ASA I and III
  • 20 - 75 years of age
  • Patient has signed an informed consent
  • Without contraindication of QL block
  • Exclusion Criteria
  • American Society of Anesthesiologists (ASA) Physical Status ≥ 4
  • Any contraindication to nerve blocks (including coagulopathy, abnormal anatomy, infection at the planned QL injection site, and amide-type local anesthetic allergy) pregnancy or breast-feeding
  • Severe obesity (body mass index≥ 35 kg/m2)
  • Patients with a history of significant neurological, psychiatric, neuromuscular, cardiovascular, pulmonary, renal or hepatic disease
  • Allergy to NSAIDs

Exclusion Criteria

  • Not provided

Arms & Interventions

Placebo QL block

30 ml single shot QL block with saline 0.9%

Intervention: normal saline

Active QL block

30 ml single shot QL block with 0.25% levo-bupivacaine

Intervention: levo-bupivacaine

Outcomes

Primary Outcomes

cumulative morphine consumption

Time Frame: 1 hour

Similar Trials